PhRMA
OCTOBER 13, 2022
Our industry is at the forefront of fighting the annual influenza virus. I recently had the chance to connect with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus about how the industry is working to fight the annual flu and what lessons learned during COVID-19 are allowing us to better respond to influenza.
Drug Topics
OCTOBER 13, 2022
From biosimilars to artificial intelligence, these are the trends poised to take community pharmacy by storm.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
OCTOBER 13, 2022
Jeremy Graff, chief scientific officer at IMV, discusses why the development of viable cancer vaccines is a bit more slow-going in comparison to the fast-paced development of COVID-19 vaccines during the pandemic.
European Pharmaceutical Review
OCTOBER 13, 2022
Scientists at MIT have demonstrated that a novel robotic capsule could potentially replace conventional biologic injection methods by tunnelling through the intestinal mucus barrier to deliver insulin. The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 13, 2022
New research suggests that ketamine can help rehabilitate those who suffer from an eating disorder, and it is important to recognize the root cause of this mental health crisis.
STAT
OCTOBER 13, 2022
Research often proceeds in a logical progression, new studies building upon a detailed understanding of the underlying processes revealed by earlier work. But a new brain imaging technique that can directly track the activity of neurons emerged from one of academics’ favorite questions: “What would happen if we tried doing it this way?
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 13, 2022
South Korea’s anti-trust regulator has fined AstraZeneca and a local generic drugmaker a total of $1.8 million for striking a deal that thwarted rivals from marketing a cancer treatment, the latest instance in which a global pharmaceutical company has been cited for anticompetitive behavior. In this case, the local company, Alvogen, reportedly agreed to suspend plans to release a version of an AstraZeneca medication called Zoladex, which is used to combat prostate and breast cancer.
Pharmacy Times
OCTOBER 13, 2022
Panelists at the AMCP Nexus conference discuss the burden of undertreated and untreated chronic kidney disease.
STAT
OCTOBER 13, 2022
The biopharma industry is failing Americans, economically and medically. U.S. biotechnology and pharmaceutical companies, like all for-profit corporations, have a primary duty baked into their corporate charters: maximize profits and shareholder value. Unlike companies in other industries, however, biopharma companies have a special advantage: their products have market exclusivity upon Food and Drug Administration approval, which can be leveraged to maximize pricing for a specified period.
Pharmacy Times
OCTOBER 13, 2022
The availability of bivalent mRNA COVID-19 boosters, which provide broader protection, will likely increase vaccine demand in the fall.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
OCTOBER 13, 2022
Examining the benefits of using flash glucose monitoring in patients with type 1 diabetes.
STAT
OCTOBER 13, 2022
BOSTON — BioNTech CEO Uğur Şahin had been in marathon meetings since he arrived in this city three days earlier, but if his energy had flagged it didn’t show. The clock had not even struck 8 a.m., and there was Şahin, in front of a table at the Four Seasons strewn with continental breakfast, deep in discussion with HIV expert Bruce Walker of the Ragon Institute.
Pharmacy Times
OCTOBER 13, 2022
Experts discuss the clinical and economic impact of misdiagnosing bipolar I disorder as major depressive disorder.
STAT
OCTOBER 13, 2022
In the numbers game of disease statistics, type 1 diabetes takes a back seat to type 2 diabetes, which accounts for more than 95% of diabetes cases around the globe. But the impact of type 1 diabetes (T1D), which tends to emerge earlier in life and can quickly kill an individual if it goes unrecognized or untreated, is huge. Its global burden, however, hasn’t been well understood — until now.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
OCTOBER 13, 2022
GSK’s vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also one with considerable competition, so needs strong data to support the programme. Thankfully for the company, it seems to be so. This morning, GSK revealed the results from its pivotal AReSVi-006 trial of the RSV shot – called RSVPreF3 OA – having said earlier this year that the study was positive.
STAT
OCTOBER 13, 2022
Every two years since 1994, scientists have come together for an experiment — better described as a competition — where teams of computational biologists try to predict what proteins will look like in 3D given their amino acid sequence. In the first 24 years, none of the entrants scored better than around 40 out of 100 for the most difficult targets.
pharmaphorum
OCTOBER 13, 2022
Day 2 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview. Click here or the image below to read Reuters: Pharma 2022 Live coverage. The post Reuters Pharma 2022 – Day 2 coverage appeared first on.
STAT
OCTOBER 13, 2022
Relmada Therapeutics said Thursday that its experimental treatment for depression failed to achieve the primary goals of a large clinical trial, a significant setback for the company’s only medicine in clinical development. The drug, a pill called REL-1017, did not show a statistically significant, anti-depressive benefit compared with a placebo.
Drug Store News
OCTOBER 13, 2022
As beauty brands continue to meet the ever-growing demands of consumers, many are turning to technology to level up everyday products that range from hair stylers to skin care tools.
STAT
OCTOBER 13, 2022
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the Pharmalot campus, where things have settled down now that the short person has returned to the institution of higher learning and the official mascot has assumed his formal snoozing position. As for us, we are dutifully concocting a few needed cups of stimulation as we dig in for another busy day — our choice today is cinnamon hazelnut.
pharmaphorum
OCTOBER 13, 2022
It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to become weak and fragile, making them more likely to break due to a fall or even something as minor as a sudden movement. The condition is the most common chronic bone disease, which is more often seen in the elderly population.
STAT
OCTOBER 13, 2022
What’s going on at biotech’s lobbying organization? Where does mRNA go from here? And what happens when startups close down? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain the abrupt departure of the CEO of BIO, the lobbying group representing biotech on Capitol Hill, and its wider implications.
Pharma Tutor
OCTOBER 13, 2022
DRUG REPURPOSING : A REVIEW. About Authors 1 AGARWAL POONAM*, 2 RATHORE KAMAL SINGH, KAVITA VIJAY 2 1 Department of Pharmaceutics, Bhopal Nobles’ Collage of Pharmacy Udaipur, Rajasthan, 2 Faculty, Jaipur, College of Pharmacy, Jaipur India, 313001. Email : charmiagarwal823@gmail.com. admin. Thu, 10/13/2022 - 15:56. Tags. Articles. Review Articles.
Compounding Pharmacy of America
OCTOBER 13, 2022
Fasting—or engaging in extended periods where you don’t consume any food—can be a key part of jump-starting a new diet or detox plan and is even a component of religious practices for some. Some nutritional plans may include limited versions of fasting, where the dieter may be allowed certain, specific foods. Healthy fasting plans will […]. The post Female and Fasting Over 40?
Drug Store News
OCTOBER 13, 2022
Melanie Loftus’ dream of establishing a charitable pharmacy came true last year when she opened the doors of the Hope Pharmacy at the Hope Clinic.
PharmaVoice
OCTOBER 13, 2022
President Susan Sobolov discusses how the startup is building on the work of two powerhouse Yale scientists to advance candidates for viruses — and beyond.
Drug Topics
OCTOBER 13, 2022
The emergency use authorization amendments extend availability of the bivalent booster to young children.
Pharmacy Times
OCTOBER 13, 2022
Women who make a difference in the industry honored on #WomenPharmacistDay.
PharmaVoice
OCTOBER 13, 2022
As the oral biologic market heats up, Rani Therapeutics is looking to dominate the field with its robotic pill for treatment of chronic conditions.
European Pharmaceutical Review
OCTOBER 13, 2022
Astellas will present results from a Phase III clinical study evaluating fezolinetant, an investigational oral, non-hormonal compound being studied to potentially treat vasomotor symptoms (VMS) associated with menopause. Fezolinetant is designed as a selective neurokinin 3 (NK3) receptor antagonist. The SKYLIGHT 4 trial results demonstrate the 52-week safety and tolerability of fezolinetant 30mg and 45mg administered once daily.
Drug Store News
OCTOBER 13, 2022
DSN spoke with Walgreens’ Brad Ulrich about how the retailer is helping its pharmacists better serve patients.
European Pharmaceutical Review
OCTOBER 13, 2022
The National Institute for Health and Care Excellence (NICE) is set to work with five health technology assessment (HTA) bodies to find solutions to common challenges in the sector, such as working with regulators and evaluating digital health technologies. In addition to NICE, the bodies involved are: Canadian Agency for Drugs and Technologies in Health (CADTH).
Drug Store News
OCTOBER 13, 2022
Ghost Legend All Out, a high-stimulant pre-workout, is available in blue raspberry and Warheads sour green apple flavors.
Pharmaceutical Technology
OCTOBER 13, 2022
Oncotelic Therapeutics has received a contract from the US Biomedical Advanced Research and Development Authority (BARDA) to develop OT-101 to treat long-term effects of respiratory distress after Covid-19 infection. Under the contract, the company will collect the long-term clinical data from patients with Covid-19 in Peru and Argentina, where the C001-2020-01 trial was carried out.
Expert insights. Personalized for you.
228 
Let's personalize your content